My HPRA: Register

Pharmacy level recall of one batch of Fluphenazin-neuraxpharm D25 Solution for Injection (exempt medicinal product)

Notice type: Recall

Date: 08/06/2023

 We wish to advise you that batch number 200229, expiry date 08/2023, of Fluphenazin-neuraxpharm D25 Solution for Injection is being recalled with immediate effect.

This recall is going to pharmacy level. 

The reason for the recall is that out of specification results for related substances were detected in units from the batch.

The batch subject to recall was supplied by Uniphar and Medisource.  Download a copy of the Uniphar Recall Letter or the Medisource Recall Letter.

Product name or type:
Fluphenazin-neuraxpharm D25 Solution for Injection

Recall Classification:
Pharmacy level recall

Target Audience:
Pharmacists 

Actions To Be Taken:

Information for pharmacists:
Pharmacists are requested to perform the following actions:
  1. Check your current inventory and immediately quarantine any units of the batch within your pharmacy. For hospital pharmacies, this includes units at wards, clinics and any other relevant locations within the hospital.
  2. If you have supplied units from the  batch to any other pharmacy, clinic or other such establishment, please forward a copy of the relevant recall letter to them, and request they quarantine and return any unused units to you.
  3. Return quarantined stock to your wholesaler by 23rd June 2023, where full credit will be issued.


Information for patients:
As the recall is to pharmacy level, patients are not required to take any action. 

« Back